Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

TME March 17, 2026

Tencent Music Entertainment Group Q4 2025 Earnings Call - AI songs hit the charts as IP, live events and SVIP reshape revenue mix

Tencent Music closed 2025 with healthy top-line growth and an explicit strategic pivot: double down on IP, live experiences and higher-value memberships while wiring AI across creation, curation and c...

  • Q4 2025 total revenue was CNY 8.6 billion, up 16% year-on-year, driven by online music services growth.
  • Music subscription revenue in Q4 2025 was CNY 4.6 billion, up 13% year-on-year; full-year music subscription revenue was reported at CNY 17.7 billion, up 16% year-on-year.
  • Non-subscription music services accelerated: Q4 revenues from music services other than subscriptions were CNY 2.5 billion, up 41% year-on-year. Management emphasized advertising, offline performances and artist-related merchandise as growth engines.
  • +11 more takeaways
ATAT March 17, 2026

Atour Lifestyle Holdings Fourth Quarter and Full Year 2025 Earnings Call - Retail-led surge and 2,015-hotel milestone set stage for brand-led growth

Atour closed 2025 having hit its 2,000 Premier Hotels target and pivoted from scale to brand-led expansion, while its retail arm, Atour Planet, went from supporting act to growth engine. Retail revenu...

  • Atour completed its 2,000 Premier Hotels strategic target, operating 2,015 hotels by year-end 2025, and has a development pipeline of 779 hotels.
  • The group opened 488 new hotels in 2025 while proactively closing 92 underperforming properties to preserve experience consistency and brand value.
  • Q4 RevPAR was RMB 335.7, or 99.6% of Q4 2024 levels; for mature hotels (in operation >18 months) Q4 RevPAR was 96% of 2024.
  • +12 more takeaways
HUYA March 17, 2026

HUYA Inc Q4 2025 Earnings Call - Game Push Validated by Goose Goose Duck Mobile Breakout

HUYA returned to topline growth in 2025, driven not by livestreaming but by a rapid pivot into game-related services, advertising, and publishing. Q4 revenues rose 16% year over year to CNY 1.74 billi...

  • Q4 2025 total net revenues CNY 1.74 billion, up 16% year over year, the highest in the last 10 quarters.
  • Full year 2025 revenue CNY 6.5 billion, up 7% year over year, HUYA says it has returned to growth.
  • Game-related services, advertising and other revenues grew 59% YoY in Q4 to CNY 593 million, and full-year rose to CNY 1.91 billion from CNY 1.33 billion.
  • +12 more takeaways
FINV March 16, 2026

FinVolution Group Q4 2025 Earnings Call - International Growth Buoys Results While China Retrenches; 2026 Revenue Guided Down 5%-15%

FinVolution closed 2025 with resilient top-line and profit despite a pullback in China. Full-year group revenue was RMB 13.6 billion, up 3.8% year-over-year, and net profit rose to RMB 2.5 billion, up...

  • Full-year 2025 group revenue RMB 13.6 billion, up 3.8% year-over-year; net profit RMB 2.5 billion, up 6.6%.
  • Total transaction volume for 2025 was RMB 200 billion, down 2.9% year-over-year, reflecting China weakness.
  • International business grew strongly in 2025: volume +38.6% and revenue +32.0% year-over-year; international revenue contribution rose to 31% for the quarter (from 21% a year ago).
  • +16 more takeaways
SMTC March 16, 2026

Semtech Corporation Q4 FY2026 Earnings Call - Data center momentum, HieFo deal lifts optics content and power-efficiency edge

Semtech closed FY2026 with a record $1.05 billion in revenue and clear momentum out of the data center franchise. Management framed the HieFo acquisition as a step-change: adding indium phosphide gain...

  • Record FY2026 revenue of $1.05 billion, up 15% year over year, and Q4 net sales of $274.4 million, up 9% year over year.
  • Management expects data center revenue to grow over 50% year over year in fiscal 2027, driven by ACC, 1.6T FiberEdge ramps, and linear equalizers onboard.
  • Semtech acquired HieFo, gaining indium phosphide expertise: gain chips and CW lasers used in tunable lasers and high-efficiency transceivers.
  • +15 more takeaways
LIDR March 16, 2026

AEye Fourth Quarter 2025 Earnings Call - Commercial Momentum Accelerates with Apollo and Stratos as Cash Runway Extends into 2028

AEye says 2025 was the year it moved from lab to lanes, converting evaluation work into a broader commercial pipeline while shoring up the balance sheet. The company closed the year with $86.5 million...

  • AEye ended 2025 with $86.5 million in cash and marketable securities, and management says the company is funded well into 2028.
  • Q4 GAAP net loss was $7.3 million, or $0.17 per share, improved from a $9.3 million GAAP loss in Q3 2025; non-GAAP net loss was $6.8 million, or $0.15 per share.
  • Q4 cash burn excluding financing rose to $7.5 million from $6.4 million in Q3, driven by higher engineering costs, professional services, insurance, and purchases of long-lead components.
  • +12 more takeaways
DCGO March 16, 2026

DocGo Q4 2025 Earnings Call - SteadyMD lifts guidance, path to adjusted EBITDA profitability in H2 2026, strategic review launched

DocGo closed 2025 with a mixed quarter: revenue beat the top end of guidance at $74.9 million, but adjusted EBITDA showed an ~$11 million loss as one-time wind down costs from migrant programs dented ...

  • Q4 revenue was $74.9 million, while the company reported an adjusted EBITDA loss of roughly $11.3 million to $11.6 million for the quarter.
  • DocGo raised full-year 2026 revenue guidance to $290 million to $310 million, up from $280 million to $300 million, and tightened adjusted EBITDA loss guidance to $5 million to $10 million from a prior $15 million to $25 million.
  • SteadyMD was the standout, generating more than $8 million in revenue in Q4 (DocGo recorded $6.1 million post-acquisition), with full-year patient interactions rising to over 4 million from 2.5 million a year earlier and gross margins improving from ~30% to 37%.
  • +12 more takeaways
BW March 16, 2026

Babcock & Wilcox Enterprises Q4 2025 Earnings Call - $2.4B Base Electron win pushes AI data center play and lifts 2026 adjusted EBITDA guide

Babcock & Wilcox announced a material shift in scale and strategy, converting a limited notice to proceed into a $2.4 billion full notice with Base Electron, intended to supply 1.2 gigawatts of grid-c...

  • Babcock & Wilcox moved from a limited notice to proceed to a full notice, booking a $2.4 billion contract with Base Electron to deliver 1.2 GW of grid-connected power for AI data center campuses.
  • Of the Base Electron contract, just over $430 million is fixed price for boilers and steam turbines, with the remainder structured as cost-plus; Applied Digital is backstopping Base Electron's obligations.
  • Management raised 2026 adjusted EBITDA guidance to $80 million-$100 million, citing both the Base Electron contract and stronger parts and services demand as drivers.
  • +12 more takeaways
PLBY March 16, 2026

Playboy, Inc. Q4 2025 Earnings Call - UTG China Deal to Slash Debt and Accelerate Media-Led Growth

Playboy closed 2025 having turned the corner from restructuring to growth. The company reported Q4 revenue of $34.9 million, net income of $3.6 million, and a fourth consecutive quarter of positive ad...

  • Q4 revenue was $34.9 million, up from $33.5 million in Q4 2024, paced by licensing and Honey Birdette strength.
  • Net income improved to $3.6 million, or $0.03 per share, versus a $12.5 million loss a year earlier.
  • Adjusted EBITDA was $7.1 million in Q4, marking four consecutive quarters of positive adjusted EBITDA; excluding litigation, adjusted EBITDA would have been $8.0 million.
  • +11 more takeaways
ASRT March 16, 2026

Assertio Holdings Fourth Quarter and Full Year 2025 Earnings Call - Rolvedon relabel launch in Q2 2026 to drive revenue recovery and margin expansion

Assertio says 2026 is essentially a Rolvedon story. Management completed integration and relabeling work in Q4 2025, pulled forward channel shipments into the prior quarter to avoid supply disruption,...

  • Rolvedon is the companys core growth engine, with IP protection into 2039 and management targeting lifecycle management to maximize long-term value.
  • Newly labeled Rolvedon sales are expected to begin in the second quarter of 2026 after a distribution and relabel transition completed in Q4 2025.
  • Management pulled forward roughly two quarters of wholesaler demand into Q3 2025 to ensure uninterrupted patient supply, which depressed reported Q4 2025 Rolvedon revenue.
  • +14 more takeaways